Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

Jonas Feldheim; Almuth F. Kessler; Dominik Schmitt; Lara Wilczek; Thomas Linsenmann; Mathias Dahlmann; Camelia M. Monoranu; Ralf-Ingo Ernestus; Carsten Hagemann; Mario Löhr

doi:10.2147/OTT.S176549

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

Jonas Feldheim, Almuth F. Kessler, Dominik Schmitt, Lara Wilczek, Thomas Linsenmann, Mathias Dahlmann, Camelia M. Monoranu, Ralf-Ingo Ernestus, Carsten Hagemann, Mario Löhr

Department of Neurology

Research output: Contribution to journal › Original Article › peer-review

Original language	English
Journal	OncoTargets and Therapy
Volume	2018
DOIs	https://doi.org/10.2147/OTT.S176549
Publication status	Published - Dec 2018

Access to Document

10.2147/OTT.S176549

Cite this

Feldheim, J., Kessler, A. F., Schmitt, D., Wilczek, L., Linsenmann, T., Dahlmann, M., Monoranu, C. M., Ernestus, R.-I., Hagemann, C., & Löhr, M. (2018). Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients. OncoTargets and Therapy, 2018. https://doi.org/10.2147/OTT.S176549

@article{8f61671298b645f19bbdc0011864e4f1,

title = "Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients",

author = "Jonas Feldheim and Kessler, {Almuth F.} and Dominik Schmitt and Lara Wilczek and Thomas Linsenmann and Mathias Dahlmann and Monoranu, {Camelia M.} and Ralf-Ingo Ernestus and Carsten Hagemann and Mario L{\"o}hr",

year = "2018",

month = dec,

doi = "10.2147/OTT.S176549",

language = "English",

volume = "2018",

journal = "OncoTargets and Therapy",

issn = "1178-6930",

}

Feldheim, J, Kessler, AF, Schmitt, D, Wilczek, L, Linsenmann, T, Dahlmann, M, Monoranu, CM, Ernestus, R-I, Hagemann, C & Löhr, M 2018, 'Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients', OncoTargets and Therapy, vol. 2018. https://doi.org/10.2147/OTT.S176549

TY - JOUR

T1 - Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

AU - Feldheim, Jonas

AU - Kessler, Almuth F.

AU - Schmitt, Dominik

AU - Wilczek, Lara

AU - Linsenmann, Thomas

AU - Dahlmann, Mathias

AU - Monoranu, Camelia M.

AU - Ernestus, Ralf-Ingo

AU - Hagemann, Carsten

AU - Löhr, Mario

PY - 2018/12

Y1 - 2018/12

UR - https://doi.org/10.2147/OTT.S176549

U2 - 10.2147/OTT.S176549

DO - 10.2147/OTT.S176549

M3 - Original Article

SN - 1178-6930

VL - 2018

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

ER -

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

Access to Document

Other files and links

Cite this